Superior Outcomes


 

Colorectal cancer remains the second leading cause of cancer-related deaths in the United States. With early detection, colorectal cancer is highly treatable – and often curable.

As risk begins to rise in the 40s, the American Cancer Society recommends a colonoscopy by age 45, with earlier evaluation for individuals with a family history of colorectal cancer, inflammatory bowel disease, certain hereditary conditions, or other contributing health factors. During your consultation, Dr. Araghizadeh provides a thoughtful, personalized assessment and tailors a screening strategy that reflects the highest standard of patient care and supports your long-term health.

For patients requiring surgery, Dr. Araghizadeh delivers an elevated surgical experience—combining the latest technologies, including the Intuitive dv-5 robotic platform, with evidence-based, expertly designed Enhanced Recovery Pathways. This approach not only supports a quicker, smoother recovery but consistently achieves surgical outcomes that surpass nationally recognized benchmarks. Explore Dr. Araghizadeh’s superior surgical outcomes

Happy middle-aged man

Surgical Outcomes & Quality Dashboard

Comparative Performance: Dr. Araghizadeh vs. National Benchmarks

Length of Stay (LOS)

2.1 Days

National Benchmark: 6 Days

Source: University Healthcare Consortium/Colorectal Surgery LOS 2020

Anastomotic Leak Rate - A Critical Measure of Safety

1.1%

National Benchmark: 10%

Source: National Inpatient Sample NSQIP Database, 2016-2023

30-Day Hospital Readmission Rate

4.3%

National Benchmark: 14%

Source: American College of Surgeons NSQIP Database, 2016-2023

Comparative Performance Indicators

1,000+ Robotic/Minimally Invasive Operations

  • Dr. Araghizadeh
  • National Benchmark
Length of Hospital Stay (LOS)
2.1 Days
 
6 Days
 
Anastomotic Leak Rate - A Critical Measure of Safety
1.1%
 
10%
 
30-Day Readmission Rate (%)
4.3%
 
14%
 
Farshid Araghizadeh, MD, MBA
3025 N Tarrant Parkway
Suite 300
Fort Worth, TX 76177